Sumitomo Chemical Company, Limited
Notice Regarding Recognition of Equity Method Investment Loss
In the third quarter of the fiscal year ending March 2026, an equity method investment loss of 15,873 million yen was recorded due to the poor performance of an equity-method affiliate.
Key Figures
- Equity Method Investment Loss: 15,873 million yen (Consolidated Q3 FY2026 accounting period)
- Target Company: Rabigh Refining and Petrochemical Company
- Consolidated Accounting Period: 2025-10-01 to 2025-12-31
AI要約
Overview of Equity Method Investment Loss
During the consolidated accounting period of Q3 for the fiscal year ending March 2026 (October 1, 2025 to December 31, 2025), Sumitomo Chemical Company, Limited recorded an equity method investment loss of 15,873 million yen due to the poor performance of Rabigh Refining and Petrochemical Company, an equity-method affiliate.
Impact on Business Performance
This investment loss is reflected in the '[Financial Summary for Q3 FY2026 (IFRS) (Consolidated)]' announced on the same day, negatively affecting the consolidated financial results. Specific financial figures and year-over-year details are unknown.
